Tivic Health Systems, Inc. (TIVC)
Pre-market:
| Previous close | 0.4850 |
| Open | 0.5000 |
| Bid | 0.3367 x 200 |
| Ask | 0.6073 x 200 |
| Day's range | 0.4669 - 0.5000 |
| 52-week range | 0.4510 - 21.8000 |
| Volume | |
| Avg. volume | 712,748 |
| Market cap | 694,060 |
| Beta (5Y monthly) | 2.83 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -10.4000 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireTivic Reports First Quarter 2024 Financial Results and Subsequent Events
SAN FRANCISCO, May 15, 2024--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its first quarter 2024 financial results with discussion of subsequent events.
Business WireTivic Health to Report Q1 2024 Financial Results and Subsequent Events on May 15th Via Conference Call and Webcast
SAN FRANCISCO, May 13, 2024--Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it will report its Q1 2024 financial results via pre-recorded conference call and webcast on Wednesday, May 15th at 1:30 PM PT / 4:30 PM ET.
Business WireTivic Health Announces Closing of $4.0 Million Public Offering
SAN FRANCISCO, May 13, 2024--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the closing of its previously announced public offering of an aggregate of 4,710,000 shares of its common stock, Series A warrants to purchase up to 4,710,000 shares of common stock and Series B warrants to purchase up to 7,065,000 shares of common stock, at a combined public offering price of $0.85 per share and accompan
